chr15-84643474-C-CG

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PVS1_ModerateBP6BS1

The NM_032856.5(WDR73):​c.1132dupC​(p.Arg378ProfsTer12) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,553,856 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00070 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000096 ( 1 hom. )

Consequence

WDR73
NM_032856.5 frameshift

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: -1.55

Publications

2 publications found
Variant links:
Genes affected
WDR73 (HGNC:25928): (WD repeat domain 73) The protein encoded by this gene is thought to contain multiple WD40 repeats. WD40 repeats are motifs that contain 40-60 amino acids, and usually end with Trp-Asp (WD). This protein is found in the cytoplasm during interphase, but accumulates at the spindle poles and astral microtubules during mitosis. Reduced expression of this gene results in abnormalities in the size and morphology of the nucleus. Mutations in this gene have been associated with Galloway-Mowat syndrome PMID: 25466283), which is a rare autosomal recessive disorder that affects both the central nervous system and kidneys. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015]
WDR73 Gene-Disease associations (from GenCC):
  • Galloway-Mowat syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • CAMOS syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Galloway-Mowat syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0044 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
BP6
Variant 15-84643474-C-CG is Benign according to our data. Variant chr15-84643474-C-CG is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 286528.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=3, Likely_benign=1}.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000696 (106/152192) while in subpopulation AFR AF = 0.00253 (105/41530). AF 95% confidence interval is 0.00214. There are 0 homozygotes in GnomAd4. There are 46 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WDR73NM_032856.5 linkc.1132dupC p.Arg378ProfsTer12 frameshift_variant Exon 8 of 8 ENST00000434634.7 NP_116245.2 Q6P4I2Q6PJL8Q5RKY8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WDR73ENST00000434634.7 linkc.1132dupC p.Arg378ProfsTer12 frameshift_variant Exon 8 of 8 1 NM_032856.5 ENSP00000387982.3 Q6P4I2

Frequencies

GnomAD3 genomes
AF:
0.000697
AC:
106
AN:
152074
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00254
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000181
AC:
29
AN:
159916
AF XY:
0.000142
show subpopulations
Gnomad AFR exome
AF:
0.00221
Gnomad AMR exome
AF:
0.000120
Gnomad ASJ exome
AF:
0.000117
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000967
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000956
AC:
134
AN:
1401664
Hom.:
1
Cov.:
33
AF XY:
0.0000969
AC XY:
67
AN XY:
691666
show subpopulations
African (AFR)
AF:
0.00248
AC:
79
AN:
31838
American (AMR)
AF:
0.0000837
AC:
3
AN:
35850
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25172
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36034
South Asian (SAS)
AF:
0.0000252
AC:
2
AN:
79422
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49648
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5162
European-Non Finnish (NFE)
AF:
0.0000407
AC:
44
AN:
1080446
Other (OTH)
AF:
0.000103
AC:
6
AN:
58092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000696
AC:
106
AN:
152192
Hom.:
0
Cov.:
32
AF XY:
0.000618
AC XY:
46
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.00253
AC:
105
AN:
41530
American (AMR)
AF:
0.0000654
AC:
1
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68002
Other (OTH)
AF:
0.00
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000728
Hom.:
0
Bravo
AF:
0.000767

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Oct 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 31, 2022
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Frameshift variant predicted to result in protein elongation as the last amino acid is replaced with 11 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; Has not been previously published as pathogenic or benign to our knowledge -

Mar 28, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Galloway-Mowat syndrome 1 Uncertain:1
Nov 16, 2022
Johns Hopkins Genomics, Johns Hopkins University
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

WDR73-related disorder Benign:1
May 06, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-1.6
Mutation Taster
=175/25
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs747109506; hg19: chr15-85186705; COSMIC: COSV100822053; COSMIC: COSV100822053; API